99% Savings - Buy Just @1 Rs X
Lodoz 2.5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Other than this, Lodoz 2.5 Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Lodoz 2.5 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Lodoz 2.5 Tablet have been listed ahead. Usually, these side effects of Lodoz 2.5 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Lodoz 2.5 Tablet is Safe for pregnant women and Safe for women who are breastfeeding. It is important to know if Lodoz 2.5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Lodoz 2.5 Tablet related warnings section.
Lodoz 2.5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Lodoz 2.5 Tablet in conditions like Diabetes, Asthma, Liver Disease. Other contraindications of Lodoz 2.5 Tablet have been discussed in the sections ahead.
Drug reaction of Lodoz 2.5 Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Lodoz 2.5 Tablet is considered not safe while driving, and is not addictive.
Lodoz 2.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Lodoz 2.5 Tablet safe for pregnant women?
Lodoz is safe for pregnant women.
Is the use of Lodoz 2.5 Tablet safe during breastfeeding?
Lodoz does not show any side effects in breastfeeding women.
What is the effect of Lodoz 2.5 Tablet on the Kidneys?
Lodoz rarely affects the kidneys.
What is the effect of Lodoz 2.5 Tablet on the Liver?
Very few cases of side effects of Lodoz on the liver have been reported.
What is the effect of Lodoz 2.5 Tablet on the Heart?
Very few cases of side effects of Lodoz on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Lodoz 2.5 Tablet unless your doctor advises you to do so -
Is this Lodoz 2.5 Tablet habit forming or addictive?
Forming a habit of Lodoz 2.5 Tablet has not been reported.
Interaction between Food and Lodoz 2.5 Tablet
Some foods when eaten with Lodoz 2.5 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Lodoz 2.5 Tablet
Consuming Lodoz 2.5 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 229
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bisoprolol An (bisoprolol fumarate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bisoprolol Sandoz® (bisoprolol fumarate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448